You are here

05-12-2016 | © Portrait: Katie Van Geyte | © Illustration: Microscopic image of the PFKFB3 project – Results published in Cantelmo AR, et al., Cancer Cell 2016 Nov 8 3 mins read

Novel therapy starves the engine driving cancer cell growth

European researchers have identified a novel approach to prevent the growth of cancer tumours and inhibit them from spreading, potentially leading to highly effective treatments with fewer side effects.

20-09-2016 | Image© iStockphoto 3 mins read

New understanding of how Alzheimer’s develops

By focusing on certain actions and reactions within the brain, an EU-funded project has advanced understanding of how Alzheimer’s Disease develops. This could potentially open the door to a new era of targeted treatments.

25-08-2016 | © picture 1 min read

Regenerative therapies for heart disease

More than 3.5 million new people are diagnosed with heart failure every year in Europe, with a long-term prognosis of 50% mortality within four years. There is urgent need for more innovative, regenerative therapies with the potential to change the course of the condition.

18-07-2016 | Image: ULB — CRCN Portrait: © F.R.S.-FNRS — Jean-Michel BYL 2 mins read

Consciousness: is this what separates us from machines?

While computers can calculate or recognise faces, they are not aware of themselves (yet?). Consciousness is in the essence of human beings; its nature, however, appears to lack a reliable explanation. Prof. Axel Cleeremans is developing a new theory, the Radical Plasticity Thesis, maintaining that consciousness is a long-lasting property of our brain rather than just a static feature. In order to test it, he is taking a multidisciplinary approach including psychological studies and advanced brain imaging.

15-06-2016 | © picture 3 mins read

How migration affects children

For millions of young people around the world migration is part of their biographies. Yet we know very little about their mobility throughout their young lives because we’ve focused on just two types of moves: their first move to a new country of residence, or their parents’ migration. Prof. Mazzucato will be trying to understand the mobility patterns of youth with migrant backgrounds and how mobility affects youth's life chances.  And she is the ERC's 500th grantee in the Netherlands. 

04-05-2016 | Portrait picture: ©NWO/Ivar Pel - Research picture: Courtesy of EATINGBODIES team 2 mins read

What is eating?

Living creatures relate to their surroundings in all kinds of ways. One of these is by eating from them and excreting into them. But what is eating? Incorporating other creatures or absorbing nutrients? A need of individual bodies or a pleasure that table companions share? The ERC project EATINGBODIES has explored such questions by studying various forms of eating. 

04-05-2016 | © Katerina Rozakou 2 mins read

Dealing with irregular migration in the 21st century

The starting point of this research project is the disproportionality between the alleged “crime” of being an undocumented migrant and the sanction of deportation. But what determines the ways in which deportation is being implemented on the ground? What are the factors that prevent or expedite implementation?

01-04-2016 | Picture copyright: Ellen Wuibaux ©Council of Europe 2 mins read

Human rights under pressure

Since its establishment in 1959, the European Court of Human Rights (ECHR) has delivered more than 10,000 judgments. Verdicts are rendered on State parties that, having ratified the European Convention of Human Rights, have nonetheless violated the civil and political rights set in this international Treaty and its protocols. Through her ERC research, Prof. Eva Brems questioned the accountability and reliability of this supranational court. Is it fit for purpose?

03-02-2016 | © picture 4 mins read

Nanovaccines join the fight against cancer

How close are we to developing a successful and comprehensive vaccine for cancer? ERC grantee Prof. Yvette van Kooyk thinks that a combination of glycobiology and immunology will lead us closer than ever before. Thanks to her ground-breaking multidisciplinary team and her new approach based on sugar receptors, she has developed a nanovaccine that promises to represent the future for cancer treatment.

02-02-2016 | picture©istockphoto.com 2 mins read

Studied malaria, found cancer treatment

Malaria has always been the centre of attention for Dr Ali Salanti’s, a molecular parasitologist and an ERC grantee. With his studies, he hoped to bring new insight into pregnancy-associated malaria, to save the lives of women and their babies in areas affected by the disease. Now, Dr Salanti’s research has shifted to battling against another deadly disease: cancer. This comes after an unexpected discovery yielded ground-breaking results for the diagnosis and treatment of this illness. This is the kind of curiosity-driven research that can lead to ground-breaking serendipitous outcomes.